A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

Ten years have elapsed since the government gave its full policy support for the research field of regenerative medicine centered on iPS cells. In 2012, Shinya Yamanaka of Kyoto University was ...

Finally, this study could incentivize a larger use of Rho kinase inhibitors ... there were no observed alterations in cell shape or topology. This suggests that the monolayer topology and morphology ...